力生制药 (002393.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(力生制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度每股收益(元) -1.00------
 单季度销售毛利率(%) 52.0059.0063.0061.0051.0057.0061.0060.00
 单季度销售净利率(%) 8.0099.0014.0014.00-8.0014.0010.0014.00
 单季度净资产收益率ROE(%) -6.001.001.00-1.001.001.00
 单季度总资产净利率ROA(%) -5.001.001.00-1.001.001.00
单季度财务摘要:
 单季度营业总收入(元) 241,460,332.00254,078,180.00321,889,999.00335,604,291.00244,569,075.00287,280,220.00308,279,074.00306,461,016.00
 单季度营业总成本(元) 208,775,393.00196,904,916.00276,892,227.00286,962,183.00229,058,752.00237,902,666.00272,577,990.00259,942,595.00
 单季度营业收入(元) 241,460,332.00254,078,180.00321,889,999.00335,604,291.00244,569,075.00287,280,220.00308,279,074.00306,461,016.00
 单季度营业利润(元) 16,079,117.00298,788,038.0049,830,059.0055,108,471.00-20,916,566.0050,349,390.0037,902,918.0050,728,791.00
 单季度利润总额(元) 15,242,557.00298,937,479.0049,796,502.0056,237,794.00-21,076,515.0050,356,288.0038,295,709.0050,788,981.00
 单季度净利润(元) 19,161,774.00252,483,964.0043,681,916.0046,500,336.00-19,017,089.0040,669,840.0029,999,890.0041,953,999.00
 单季度归属母公司股东的净利润(元) 19,161,774.00252,483,964.0043,681,916.0046,500,336.00-19,017,089.0040,669,840.0029,999,890.0041,953,999.00
 单季度经营活动产生的现金流量(元) 118,037,804.00-12,116,295.0036,555,438.0057,529,079.00133,210,925.0070,750,350.0094,552,603.0032,867,367.00
 单季度投资活动产生的现金流量(元) -300,003,979.00273,294,747.00-77,148,712.00123,218,552.00167,095,751.00-237,354,432.00-72,105,988.00-13,275,891.00
 单季度筹资活动产生的现金流量(元) 6,931,943.00-66,385.00--21,069,796.00-193,052.00--
 单季度现金及现金等价物净增加(元) -175,034,232.00261,112,067.00-96,282,170.00180,747,631.00321,376,472.00-166,797,134.00-32,216,121.0019,591,476.00

前瞻产业研究院